SPECT imaging, immunohistochemical and behavioural correlations in the primate models of Parkinson's disease.

Abstract : Dopamine active transporter (DAT) single photon emission computerised tomography (SPECT) is considered a useful and practical technique for early diagnosis of Parkinson's disease (PD) and assessment of its progression. The application of this technique, particularly as a surrogate marker for therapeutic and neuroprotective trials in Parkinsonism, however, is dependent on pathological validation. In the absence of human studies, we used 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) primate models of Parkinsonism to verify correlation between the SPECT, immunohistochemical and behavioural data. The DAT SPECT data correlated strongly and significantly with the substantia nigra pars compacta tyrosine hydroxylase and Nissl cell counts as well as the behavioural scores. Within the limitations of small numbers inherent to such studies, this data provides the first attempt at pathological validation of SPECT in primates.
Type de document :
Article dans une revue
Parkinsonism and Related Disorders, Elsevier, 2007, 13 (5), pp.266-75. 〈10.1016/j.parkreldis.2006.10.009〉
Liste complète des métadonnées

http://www.hal.inserm.fr/inserm-00382300
Contributeur : Jean-Paul Issartel <>
Soumis le : jeudi 7 mai 2009 - 16:24:44
Dernière modification le : jeudi 7 mai 2009 - 17:10:50

Identifiants

Collections

UGA

Citation

Keyoumars Ashkan, Bradley Wallace, John Mitrofanis, Claudio Pollo, Pierre-Yves Brard, et al.. SPECT imaging, immunohistochemical and behavioural correlations in the primate models of Parkinson's disease.. Parkinsonism and Related Disorders, Elsevier, 2007, 13 (5), pp.266-75. 〈10.1016/j.parkreldis.2006.10.009〉. 〈inserm-00382300〉

Partager

Métriques

Consultations de la notice

88